A Study to Evaluate SHR-1139 Injection in Patients With Pyoderma Gangrenosum
Clinical trial NCT07444684 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07444684
- Sponsor
- Guangdong Hengrui Pharmaceutical Co., Ltd
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-05
- Primary completion
- 2027-06-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.